期刊文献+

西替利嗪联合反应停治疗慢性荨麻疹疗效观察 被引量:6

The Effect of Combining Cetirizine Hydrochloride With Thalidomide in the Treatment of Chronic Urticaria
下载PDF
导出
摘要 目的观察西替利嗪联合反应停(沙利度胺)治疗慢性荨麻疹的疗效。方法收集门诊慢性荨麻疹患者(其它方法治疗不理想者)采用病例随机分组,治疗组口服反应停100 mg/日,分2次口服,盐酸西替利嗪,每日1次,每次10 mg。对照组单服盐酸西替利嗪每次10 mg,每日1次。两组疗程均为4周,疗程结束,随访1个月评价。结果治疗组有效率为72.29%,对照组有效率为33.82%。两组有效率比较差异有显著性(x^2=22.34,P=0.00)。结论西替利嗪联合反应停治疗顽固性荨麻疹是一种有效方法。 Objective To observe therapeutic efficiency of cetirizine combined with thalidomide in the treatment of chronic urticaria.Methods The cases of chronic urticaria were divided into treatment group and control group.The patients in the treatment group were orally given cetirizine and thalidomide for 4 weeks,and those in the control group were only given cetirizine for 4 weeks.Results The total effective rates in treatment group and control group were 72.29% and 33.82%respectively,there was a significant difference in the effective rates in two groups(x^2=22.34,P = 0.00).Conclusion Compared with desloratadine for the treatment of chronic urticaria,cetirizine combined with thalidomide can increase clinical efficacy.
出处 《南华大学学报(医学版)》 2010年第6期786-788,共3页 Journal of Nanhua University(Medical Edition)
基金 湖南省自然科学基金[07JJ6162] 衡阳市科技局基础研究计划项目[2008KJ003]
关键词 荨麻疹 慢性 西替利嗪 反应停 Urticaria Chronic Cetirizine Thalidomide
  • 相关文献

参考文献8

  • 1荨麻疹诊疗指南(2007版)[J].中华皮肤科杂志,2007,40(10):591-593. 被引量:213
  • 2吴伊旋,沈惠风.慢性荨麻疹部分发病机制的研究进展[J].临床皮肤科杂志,2008,37(2):136-137. 被引量:146
  • 3Komorowski J,Jerczynska H,Siejka A,et al.Effect of thalido-mide affecting VEGF secretion,cell migration,adhesion and capillary tube formation of human endothelial EA.Hy 926 cells[J].Life Sciences,2006,78 (22):2558-2563.
  • 4Haslett PA,Roche P,Butlin CR,et al.Effective treatment of erythema nodosum lep rosum with thalidomide is associated with immune stimulation[J].J Infect Dec,2005,192(12):2045-2053.
  • 5Du GJ,Lin HH,Xu QT,et al.Thalidomide inhibits growth of tumors through COX-2 degradation independent of antiangiogenesis[J].Vascul Pharmacol,2005,43(2):112-119.
  • 6CuadradoMJ,Karim Y,Sanna G,et al.Thalidomide for the treatment of resistant cutaneous lupus efficacy and safety of different therapeutic regimens[J].Am J Med,2005,118(3):246-250.
  • 7Oxberry SG,Johnson MJ.Response to thalidomide in chemotherapy-resistant cutaneous T-cell lymphoma[J].Clin Oncol,2006,18 (1):86-87.
  • 8Estrada-GI,Garibay-Escobar A,Nú? ez-Vázquez A,et al.Evidence that thalidomide modifies the immune response of patients suffering from actinic prurigo[J].Int J Dermatol,2004,43 (12):893-897.

二级参考文献14

  • 1Grattan CE, Wallington TB, Warin RP, et al. A serological mediator in chronic idiopathic urticaria-a clinical, immunological and histological evaluation[J]. Br J Dermatol, 1986, 114(5): 583- 590.
  • 2Grattan CE, Francis DM, Hide M, et al. Detection of circulating histamine releasing autoantibodies with function properties of anti-IgE in chronic urticaria[J]. Clin Exp Allergy, 1991, 21(6): 695-704.
  • 3Hide M, Francis DM, Grattan CE, et al. Autoantibodies against the high-affinity IgE receptor as a cause for histamin release in chronic urticaria[J]. N Engl J Med, 1993, 328(22): 1599-1604.
  • 4Horn MP, Pachlopnik JM, Vogel M, et al. Conditional autoimmunity mediated by human natural anti-Fc (epsilon) Rialpha autoantibodies?[J]. FASEB J, 2001, 15(12): 2268-2274.
  • 5Ferrer M, Nakazama K, Kaplan AP. Complement dependence of histamin release in chronic urticaria[J]. J Allergy Clin Immunol, 1999, 104(1): 169-172.
  • 6Bobrzynski T, Fux M, Vogel M, et al. A high-affinity natural autoantibody from human curd blood defines a physiologically relevant epitope on the FcepsilonRIalpha[J]. J Immunol, 2005, 175(10): 6589-6596.
  • 7Niimi N, Francis DM, Kermani F, et al. Dermal mast cell activation by autoantibodies against the high affinity IgE receptor in chronic urticaria[J]. J Invest Dermatol, 1996,106 (5): 1001-1006.
  • 8Piconi S, Trabattoni D, Iemoli E, et al. Immune profiles of patients with chronic idiopathic urticaria[J]. Int Arch Allergy Immunal, 2002, 128(1): 59-66.
  • 9Ying S, Kikuchi Y, Meng Q, et al. TH1/TH2 cytukines and in flammatory cells in skin biopsy specimens from patients with chronic idiopathic urticaria: comparison with the allergen-induced late-phase cutaneous reaction[J]. J Allergy Clin Immunol, 2002, 109(4): 694-700.
  • 10Caproni M, Volpi W, Macchia D, et al. Infiltrating cells and related cytokines in lesional skin of patients with chronic idiopathic urticaria and positive autologous serum skin test [J]. Exp Dermatol, 2003, 12(5): 621-628.

共引文献344

同被引文献72

引证文献6

二级引证文献16

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部